 "Lupin receives US FDA nod for dementia and contraceptive drugs")
Lupin Limited has received US drug regulator’s final approvals for generic versions of Eisai Inc’s Aricept (used for treating dementia) tablet and Warner Chilcott’s Loestrin 24 Fe tablet (an oral contraceptive).
Lupin’s donepezil hydrochloride tablet (23 mg) is indicated for the treatment of dementia of the Alzheimer's type and is the generic equivalent of Aricept tablet, which had US sales of $ 52.3 million, according to IMS MAT June 2015.
Lupin has also received marketing approval for its Blisovi 24 Fe tablet (norethindrone acetate and ethinyl estradiol tablet), a generic version of Loestrin 24 Fe tablet, from the US Food and Drug Administration (US FDA). Loestrin 24 Fe tablet, which is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception, had recorded annual sales of $ 56.8 million in the US, according to IMS data.
Lupin’s donepezil hydrochloride tablet (23 mg) is indicated for the treatment of dementia of the Alzheimer's type and is the generic equivalent of Aricept tablet, which had US sales of $ 52.3 million, according to IMS MAT June 2015.
Lupin has also received marketing approval for its Blisovi 24 Fe tablet (norethindrone acetate and ethinyl estradiol tablet), a generic version of Loestrin 24 Fe tablet, from the US Food and Drug Administration (US FDA). Loestrin 24 Fe tablet, which is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception, had recorded annual sales of $ 56.8 million in the US, according to IMS data.